Position
Parallel Advisors, LLC in Cocrystal Pharma, Inc.
Back to the book · All holders of COCP
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $390$0.98 → $1.01
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 12.6K | $12.3K | — | — | — | 0.0% |
| Q1 2026 | 12.6K | $12.7K | $1.01 | $390 | $0 | 0.0% |